That head start for Novo’s combo med Xultophy? The FDA delayed it instead
Novo Nordisk’s combination diabetes drug didn’t lap Sanofi’s after all. Two weeks after the FDA put off approval of the…
Read more
VetDC nears FDA approval for dog lymphoma drug cast off by Gilead
Colorado-based VetDC, which specializes in taking experimental drugs cast off by pharma companies and turning them into veterinary therapies, just…
Canadian team creates PEDv vaccine candidate, starts field testing
Scientists in Canada have developed a prototype vaccine that may become a new tool in the ongoing battle against porcine…
FDA eases transition to new safety rules for producers of animal food
The FDA Food Safety Modernization Act (FSMA), which goes into effect starting next month, introduces tough new rules for food…
Dogs face more risk for hereditary diseases than originally assumed: Report
A comprehensive, multinational study of hereditary canine disorders reveals that about one in 6 dogs carries a genetic variant predisposing…
Jaguar losses mount as sales fall and R&D costs skyrocket
The latest financial report from Jaguar Animal Health ($JAGX) reflects a company that’s struggling to realize the promise of its…
Experts call for better testing as equine health gets an Olympic spotlight
As the Summer Olympic Games in Rio capture the world’s attention with top horses traveling there to compete, some experts…
Clinical trials in pets pose both challenges and opportunities
Late last year, Connecticut-based Kolltan Pharmaceuticals ran a clinical trial in pet dogs that showed its drug, KTN0158, substantially shrank…
Lilly’s Elanco vows to be ‘a lot bigger’ in aquaculture
Eli Lilly ($LLY) has been doubling down on its efforts to invent new animal vaccines–opening a 48,000-square-foot research facility near…
UK scientists shed light on painful tail disease in dogs
The ubiquitous wagging tail that all dogs sport is more than just a signal of a happy animal. Tails that…